A large-scale multi-omics study of cortical miRNA dysregulation in Alzheimer′s disease
MicroRNAs regulate gene expression, but their roles in Alzheimer′s disease pathology and downstream molecular changes remain incompletely characterized. We integrated cortical small RNA-sequencing data from seven datasets across six postmortem cohorts comprising 1,738 individuals with transcriptomic, proteomic, genetic, and single-nucleus data. Meta-analysis of 405 microRNAs identified 16 associated with advanced and four with intermediate neurofibrillary tangle pathology, with miR-132-3p significant in both comparisons. Five microRNAs (miR-132-3p, miR-212-3p, miR-212-5p, miR-146b-5p, miR-3200-3p) showed evidence of mediating associations between target mRNA and protein expression and tau pathology. Consensus co-expression network analysis linked the miR-132/212 family to opposing neuronal/synaptic and oligodendrocyte/myelination-related programmes. Mediated targets were enriched among tau-associated differentially expressed genes across glial cell types, particularly astrocytes. Inferred cell-type regulatory networks further highlighted miR-132-3p and miR-146b as recurrent hubs. These findings prioritize a restricted set of cortical microRNAs and associated neuronal and glial molecular programmes for mechanistic investigation in Alzheimer′s disease.
Authors
- Lars Bertram (ORCID: https://orcid.org/0000-0002-0108-124X)
- J.C. Koetsier (ORCID: https://orcid.org/0000-0002-7981-1345)
- Muhammad Aslam (ORCID: https://orcid.org/0000-0003-1817-7894)
- Melissa Schepers (ORCID: https://orcid.org/0000-0001-8090-8489)
- Safa Al‐Sarraj (ORCID: https://orcid.org/0000-0002-6783-3571)
- Joshua Harvey (ORCID: https://orcid.org/0000-0001-6423-9983)
- Jennifer L. Imm (ORCID: https://orcid.org/0000-0002-8827-8669)
- Darren M. Soanes (ORCID: https://orcid.org/0000-0001-5025-295X)
- Ehsan Pishva (ORCID: https://orcid.org/0000-0002-8964-0682)
- Claire Troakes (ORCID: https://orcid.org/0000-0002-1790-7376)
- Assia Tiane (ORCID: https://orcid.org/0000-0003-3931-8254)
- Jonathan S. Mill (ORCID: https://orcid.org/0000-0003-1115-3224)
- Morteza P Kouhsar (ORCID: https://orcid.org/0000-0001-6092-3016)
- Greg Wheildon (ORCID: https://orcid.org/0000-0002-7911-9973)
- Luke Stephen Weymouth (ORCID: https://orcid.org/0000-0002-1168-6015)
- Daniël van den Hove (ORCID: https://orcid.org/0000-0003-4047-3198)
- Marcel Schilling (ORCID: https://orcid.org/0000-0002-3453-7792)
- Laura Parkkinen (ORCID: https://orcid.org/0000-0002-3392-8564)
- Katie Lunnon (ORCID: https://orcid.org/0000-0001-7570-6065)
- Lachlan Ford MacBean (ORCID: https://orcid.org/0009-0001-2437-8329)
- Valerija Dobričić (ORCID: https://orcid.org/0000-0001-8559-1097)
- Tim Vanmierlo (ORCID: https://orcid.org/0000-0003-2912-0578)
- Valentin Laroche (ORCID: https://orcid.org/0009-0002-2952-3043)
- Byron Creese (ORCID: https://orcid.org/0000-0001-6490-6037)
- Giulia Pegoraro (ORCID: https://orcid.org/0009-0001-5206-5303)
- Grace Thomson (ORCID: https://orcid.org/0009-0009-2104-0443)
- Adam R Smith
Institutions
- King's College London (GB)
- University of Exeter (GB)
- Maastricht University (NL)
- University of Oxford (GB)
- Brunel University of London (GB)
- University of Lübeck (DE)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.64898/2026.11.16.767087
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- preprint
Funders
- Michael J. Fox Foundation for Parkinson's Research
- Cure Alzheimer's Fund
- University of Pittsburgh
- Alzheimer's Society
- National Institute for Health and Care Research
- Department of Health and Social Care
- University of Exeter
- Deutsche Forschungsgemeinschaft
- ZonMw
- Alzheimer Nederland
- National Institutes of Health
- Medical Research Council
- NIHR Oxford Biomedical Research Centre
- Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology,University College London